This information was published on 2022-11-29T09:06:29 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2315275 (IR 1696690) |
| (220) |
24 May 2022
|
| (300) |
AT, 30 Nov 2021, AM 13039/2021
|
| (511) (510) |
Class 42
Research and development services and scientific advice in the field of pharmaceuticals and diagnostics relating to alzheimer' s disease and dementia; clinical research for others in the field of pharmaceuticals and diagnostics relating to alzheimer' s disease and dementia. Class 44 Providing medical and health information in the field of Alzheimer' s disease and dementia. |
| (540) | ADVANTAGE THERAPEUTICS |
| (550) | Word |
| (730) |
ADvantage Therapeutics GmbH
|
Find out more about publications on the About page.